Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.89
-4.14 (-1.87%)
AAPL  258.31
-4.46 (-1.70%)
AMD  229.83
-8.20 (-3.44%)
BAC  51.01
-0.52 (-1.00%)
GOOG  252.34
+1.00 (0.40%)
META  733.16
-0.11 (-0.02%)
MSFT  520.49
+2.83 (0.55%)
NVDA  180.01
-1.15 (-0.63%)
ORCL  273.02
-2.13 (-0.77%)
TSLA  439.10
-3.50 (-0.79%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.